相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Vincent Camus et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS)
Harnish P. Patel et al.
AGE AND AGEING (2013)
Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer
C. Pezaro et al.
BRITISH JOURNAL OF CANCER (2013)
Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results
Lene Thoresen et al.
CLINICAL NUTRITION (2013)
Analytic Morphomics, Core Muscle Size, and Surgical Outcomes
Michael J. Englesbe et al.
ANNALS OF SURGERY (2012)
Body composition and outcome in patients undergoing resection of colorectal liver metastases
M. G. van Vledder et al.
BRITISH JOURNAL OF SURGERY (2012)
Randomized phase III clinical trial of a combined treatment with carnitine plus celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome
Clelia Madeddu et al.
CLINICAL NUTRITION (2012)
Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer
Sherif Awad et al.
CLINICAL NUTRITION (2012)
Sarcopenia During Androgen-Deprivation Therapy for Prostate Cancer
Matthew R. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Relationships Among Body Mass Index, Longitudinal Body Composition Alterations, and Survival in Patients With Locally Advanced Pancreatic Cancer Receiving Chemoradiation: A Pilot Study
Shalini Dalal et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2012)
Body Composition, Symptoms, and Survival in Advanced Cancer Patients Referred to a Phase I Service
Henrique A. Parsons et al.
PLOS ONE (2012)
Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma
Olivier Mir et al.
PLOS ONE (2012)
Worsening Central Sarcopenia and Increasing Intra-Abdominal Fat Correlate with Decreased Survival in Patients with Adrenocortical Carcinoma
Barbra S. Miller et al.
WORLD JOURNAL OF SURGERY (2012)
Physical activity for cancer survivors: meta-analysis of randomised controlled trials
Daniel Y. T. Fong et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma
Michael S. Sabel et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Age, gender, and racial differences in incidence and survival in primary CNS lymphoma
J. L. Villano et al.
BRITISH JOURNAL OF CANCER (2011)
Frailty, core muscle size, and mortality in patients undergoing open abdominal aortic aneurysm repair
Jay Soong-Jin Lee et al.
JOURNAL OF VASCULAR SURGERY (2011)
Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis
Peter D. Peng et al.
HPB (2011)
The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial
James T. Dalton et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2011)
Sarcopenia: European consensus on definition and diagnosis
Alfonso J. Cruz-Jentoft et al.
AGE AND AGEING (2010)
Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma
S. Antoun et al.
ANNALS OF ONCOLOGY (2010)
Combined Resistance and Aerobic Exercise Program Reverses Muscle Loss in Men Undergoing Androgen Suppression Therapy for Prostate Cancer Without Bone Metastases: A Randomized Controlled Trial
Daniel A. Galvao et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Association of Skeletal Muscle Wasting With Treatment With Sorafenib in Patients With Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled Study
Sami Antoun et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Sarcopenia and Mortality after Liver Transplantation
Michael J. Englesbe et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2010)
Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
Benjamin H. L. Tan et al.
CLINICAL CANCER RESEARCH (2009)
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
Carla M. M. Prado et al.
CLINICAL CANCER RESEARCH (2009)
Nonsteroidal Selective Androgen Receptor Modulators (SARMs): Dissociating the Anabolic and Androgenic Activities of the Androgen Receptor for Therapeutic Benefit
Michael L. Mohler et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
Marina Mourtzakis et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2008)
Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer
Daniel A. Galvao et al.
BJU INTERNATIONAL (2008)
Lymphoma survival patterns by WHO subtype in the United States, 1973-2003
Xuesong Han et al.
CANCER CAUSES & CONTROL (2008)
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
Carla M. M. Prado et al.
LANCET ONCOLOGY (2008)
Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity
Carla M. M. Prado et al.
CLINICAL CANCER RESEARCH (2007)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image
W Shen et al.
JOURNAL OF APPLIED PHYSIOLOGY (2004)
分享论文
